Article Details
Retrieved on: 2023-01-02 22:46:05
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The firm acquired 233,452 shares of the biopharmaceutical company's stock, valued at approximately $1,359,000. A number of other institutional ...
Article found on: www.etfdailynews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here